JERUSALEM, Jan 28 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab reported strong quarterly results on Wednesday but forecast lower net profit and revenue in 2026 on a more than $1 ...
TORONTO — Novo Nordisk Canada is considering competing with generic versions of its brand-name Ozempic and Wegovy drugs by introducing renamed, lower-priced copies of the medications. Health Canada ...
Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET Shreehas Tambe, CEO & managing director of Biocon Biologics, discusses the way that US tariff & manufacturing policy affects India's ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs. By Rebecca Robbins The Food and Drug Administration ...
The federal government will not impose tariffs on generic pharmaceuticals manufactured overseas, and instead focus on brand-name drugs, according to an Oct. 8 report from The Wall Street Journal. In a ...
Over the past six months, numerous pharmaceutical companies have announced plans to invest in new U.S. manufacturing facilities within the next decade. This so-called “onshoring,” motivated by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results